Method for repair and reconstruction of ruptured ligaments or tendons and for treatment of ligament and tendon injuries

• US 8,070,810 B2
• Filed: 01/12/2007
• Issued: 12/06/2011
• Est. Priority Date: 01/12/2006
• Status: Expired due to Fees

• Current Assignee: Histogenics Corporation (Ocugen, Inc.)
• Original Assignee: Histogenics Corporation (Ocugen, Inc.)
• Inventors: Tarrant, Laurence J. B., Kusanagi, Akihiko, Smith, Robert Lane
• Primary Examiner(s): GHERBI, SUZETTE JAIME J
• Application Number:
  US11/653,024
• Publication Number:
  US 20070162121A1
• Time in Patent Office: 1,789 Days
• Field of Search: 623 1311- 1319
• US Class Current: 623/13.12
• CPC Class Codes: A61B 17/00491 Surgical glue applicators surgical adhesives A61L24/00; two-component delivery syringes A61M5/19
• CPC Class Codes: A61B 17/1146 of tendons
• CPC Class Codes: A61B 2017/1132 End-to-end connections
• CPC Class Codes: A61F 2/08 Muscles; Tendons; Ligaments sutures A61B17/04
• CPC Class Codes: A61L 2430/10 for reconstruction of tendons or ligaments
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/386 Ligaments, tendons
• CPC Class Codes: Y10S 623/908 Bone

Abstract

A method and a means for repair and reconstruction of ruptured ligaments and tendons by in vivo or ex vivo repair and reconstruction surgical procedures. The method comprises providing a biodegradable sleeve placed around the frayed edges of an injured ligament or tendon for protecting the ligament or tendon injury with a protective shield. A composition comprising a biodegradable tissue adhesive applied on top of, around and/or between the frayed edges of the injured ligament.

Claims

1. A method for in situ repair and reconstruction of injured ligaments and tendons comprising steps of:

(a) fabricating a protective sleeve or a composite of the protective sleeve with a support matrix wherein said sleeve or said composite has flexibility and contractibility permitting its contraction and compression with extension of said sleeve;

(b) selecting a biologically acceptable biodegradable tissue adhesive having a setting time of adhesion in from about 30 seconds to about five minutes, peel strengths of at least 3N/m, tensile strength in the range of 0.8 to 1.0 MPa, and a bond strength from 1 to 6 N/cm², to have a sufficient strength to hold frayed edges of a ruptured ligament or tendon together for a time needed for said frayed edges of said ligament or tendon to grow together;

(c) surgically attaching, in situ, one end of the protective sleeve or said composite to the uninjured portion of ligament or tendon, or to the bone where the uninjured healthy ligament or tendon is attached;

(d) immobilizing, in situ, said injured ligament or tendon by surgically juxtaposing the frayed edges of the ruptured ligament or tendon to a close proximity of each other and connecting said frayed edges together using said biologically acceptable biodegradable tissue adhesive and sealing a space between and around the two edges of the ruptured ligament or tendon with said adhesive;

(e) applying, in situ, said tissue adhesive to a top of, around or in between said juxtaposed frayed edges of step (d) thereby attaching said frayed edges together and sealing an area around and between said edges with said adhesive;

(f) extending, in situ, said protective sleeve or said composite over and covering a sealed area of step (e) with said protective sleeve or said composite;

(g) attaching, in situ, a second end of said protective sleeve or said composite o an uninjured portion of the ligament or tendon or to a bone where the other end of the uninjured ligament is attached, or to a muscle where the uninjured tendon is attached; and

(h) stabilizing a site of the injury by limiting weight bearing and/or range of motion for a time needed for the frayed edges of the ruptured ligament or tendon to grow together.

2. The method of claim 1 wherein said protective sleeve or said composite is fabricated as a sheet, mesh, strands, fibers, net, fibrous sheet, fibrous mesh, fibrous netting, or from a knitted sheath comprising individual strands of yarn.

3. The method of claim 2 wherein said protective sleeve or said composite is fabricated from a biodegradable silk, a porous collagen matrix, a derivatized polymer, a bundle of yarn strands comprising one to several fibers of polymer or silk.

4. The method of claim 2 wherein a material used for fabrication of said protective sleeve or said composite is selected from the group consisting of Type I collagen, Type II collagen, Type IV collagen, gelatin, agarose, collagen containing proteoglycan, glycosaminoglycan or glycoprotein, polymer of aromatic organic acid, fibronectin, laminin, bioactive peptide growth factor, cytokine, elastin, fibrin, synthetic polymeric fibers made of polylactic, polyglycolic or polyamino acid, polycaprolactone, polyamino acid, polypeptide gel, copolymer thereof and a combination thereof.

5. The method of claim 2 wherein a material used for fabrication of a support matrix of said composite is a sol, gel, sol-gel or themio-reversible hydrogel.

6. The method of claim 1 wherein said supporting matrix of said composite is incorporated with, have embedded into or is seeded with exogenously added cells.

7. The method of claim 6 wherein said cells are fibroblasts, tenocytes, their progenitor cells, mesenchymal cells, embryonic cells or stem cells.

8. The method of claim 7 wherein said cells are adhered to a surface of said support or into said protective sleeve.

9. The method of claim 7 additionally comprising growth hormones, modulators of cell growth or pharmaceutical agents.

10. The method of claim 7 wherein said cells are autologous fibroblasts or autologous tenocytes.

11. The method of claim 1 wherein said tissue adhesive is a biologically acceptable polymer having a polymerization setting time between about one and about three minutes.

12. The method of claim 11 wherein said tissue adhesive is selected from the group consisting of a derivatized polyethylene glycol (PEG);

albumin cross-linked with a collagen compound;

polyethylene glycol (PEG) cross-linked with a collagen compound;

tetra-hydrosuccinimidyl derivatized PEG;

tetra-thiol derivatized PEG;

two-part polymer composition that rapidly foiin a matrix where at least one of the compounds is polyamino acid, polysaccharide, or polyalkylene oxide;

polyethylene glycol;

polyethylene glycol cross-linked with methylated collagen;

a copolymer of polyethylene glycol and polylactide;

a copolymer of polyethylene glycol and polyglycolide, a copolymer of polyethylene glycol and polyhydroxybutyrate;

a polymer of an aromatic organic amino acid;

a copolymer thereof, and a combination thereof.

13. The method of claim 12 wherein the tissue adhesive material is polyethylene glycol cross-linked with methylated collagen.

14. The method of claim 12 wherein said adhesive is polyhydroxybutyrate.

15. A device for in situ repair and reconstruction of injured ligament or tendon comprising a protective shield acting as an encasement for said injured ligament or tendon wherein said protective shield comprises

a flexible, contractible and biodegradable composite comprising a protective sleeve and a collagenous support matrix, said protective shield configured to be positioned, in situ, around and surrounding an injured ligament or tendon treated with a methylated collagen polyethylene glycol tissue adhesive;

wherein said support matrix of said composite is positioned, in situ, adjacent to said injured ligament or tendon and is further incorporated with, have embedded into or is seeded with exogenously added fibroblasts, tenocytes, fibroblast progenitors, tenocyte progenitors, mesenchymal cells, embryonic cells or stem cells;

wherein said support matrix is a porous sponge, honeycomb, lattice or scaffold fabricated from Type I collagen, Type II collagen, Type IV collagen derivatized collagen, cross-linked collagen, collagen containing proteoglycan, collagen containing glycosaminoglycan or collagen containing glycoprotein, a mixture thereof or a combination thereof;

wherein said protective sleeve is fabricated from a fibrous material comprised of a group of fibers having different times of degradation, wherein at least some fibers are predetermined to have degradation time from about three to about six months; and

wherein said protective sleeve is a fibrous sheath, fibrous mesh, fibrous net, fibrous strand, fibrous yarn, fibrous strand or knitted fiber wherein said fibers having the different time of degradation provide a gradual degradation of the protective sleeve and wherein during said gradual degradation of said protective sleeve the injured ligament or tendon is gradually subjected to decreasing tensile strength;

wherein a first group of fibers to degrade supports a deposition and a growth of an incipient ligament-producing fibroblast positioned adjacent to the injured ligament or a growth of an incipient tendon-producing tenocyte positioned adjacent to the injured tendon, wherein a degradation time for the first fiber is about or less than one month and wherein the first fiber is a derivatized block polyethylene glycol (PEG);

wherein a second group of fibers to degrade reinforces a strength of the protective sleeve and wherein a degradation time for the second group of fibers is from about one to about two months and wherein said second fiber is a microbially synthesized polyester polyalkanoate; and

wherein a third group of fibers to degrade provides a long-term backbone support for the protective shield and wherein a degradation time of the third group of fibers is from about three to about six months;

wherein said flexible and contractible composite is extendable and, when extended. it compresses frayed edges of an injured ligament or tendon juxtaposed together and covered with said tissue adhesive and holds said frayed edges together; and

wherein said composite comprises attachment means for attaching, in situ, a first end of said protective shield to a bone where a ligament is attached, or to a muscle where a tendon is attached, a means for protecting said frayed edges of an injured ligament or tendon juxtaposed together and covered with said tissue adhesive by extending said protective shield over said frayed edges, and a means for attaching a second end of said protective sleeve to an apposite bone or muscle where the other end of the ligament is attached.

16. The device of claim 15 wherein said cells are added to said support matrix or are adhered to a collagenous surface of said support matrix before, during or after a surgery.